Non-antibiotic prophylaxis for recurrent urinary-tract infections;Niet-antibiotische profylaxe van recidiverende urineweginfecties

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 10, 2006, Pages 541-544

  Beerepoot, M A J ^a   Ter Riet, G ^a   Verbon, A ^b   Nys, S ^b   De Reijke, T M ^a   Geerlings, S E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; CRANBERRY; HUMAN; INFECTION PREVENTION; LACTOBACILLUS; PATHOGENESIS; RECURRENT INFECTION; REVIEW; URINARY TRACT INFECTION;

FEMALE; HUMANS; LACTOBACILLUS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; URINARY TRACT INFECTIONS; VACCINIUM MACROCARPON;

EID: 33644956354     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Haaren K van, Visser HS, Vliet S van, Timmermans AE, Yadava R, Geerlings SE, et al. NHG-standaard Urineweginfecties (tweede herziening). Huisarts Wet. 2005;48:341-52.
2. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Dis Mon. 2003;49:53-70.
3. Ellis AK, Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract. 2000;13:392-7.
4. Polder JJ, Takken J, Meerding WJ, Kommer GJ, Stokx LJ. Kosten van ziekten in Nederland. De zorgeuro ontrafeld. Bilthoven: RIVM; 2002.
5. Albert X, Huertas I, Pereiro II, Sanfelix J, Gosalbes V, Perrota C. Antibiotics for preventing recurrent urinary tract infection in non-pregnant women [Cochrane review]. Cochrane Database Syst Rev. 2004;(3):CD001209.
6. Gupta K, Scholes D, Stamm WE. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999;281:730-8.
7. Murray BE, Rensimer ER, DuPont HL. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim-sulfamethoxazole. N Engl J Med. 1982;306:130-5.
8. Mandell GL, Bennet JE, Dolin R. Principles and practice of infectious diseases. 5th ed. New York: Churchill Livingstone; 2000.
9. Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect Immun. 1985;47:84-9.
10. Stapleton A. Novel approaches to prevention of urinary tract infections. Infect Dis Clin North Am. 2003;17:457-71.
11. Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. MedGenMed. 2004;6:49.
12. Raz R, Stamm WE. A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993;329:753-6.
13. Reid G, Bruce AW. Selection of lactobacillus strains for urogenital probiotic applications. J Infect Dis. 2001;183(Suppl 1):S77-80.
14. Reid G, Bruce AW, Fraser N, Heinemann C, Owen J, Henning B. Oral probiotics can resolve urogenital infections. FEMS Immunol Med Microbiol. 2001;30:49-52.
15. Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, et al. Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunol Med Microbiol. 2003;35:131-4.
16. Svensson M, Frendeus B, Butters T, Platt F, Dwek R, Svanborg C. Glycolipid depletion in antimicrobial therapy. Mol Microbiol. 2003;47:453-61.
17. Langermann S, Ballou Jr WR. Vaccination utilizing the FimCH complex as a strategy to prevent Escherichia coli urinary tract infections. J Infect Dis. 2001;183(Suppl 1):S84-6.
18. Bauer HW, Alloussi S, Egger G, Blumlein HM, Cozma G, Schulman CC. A long-term, multicenter, double-blind study of an Escherichia coli extract (OM-89) in female patients with recurrent urinary tract infections. Eur Urol. 2005;47:542-8.
19. Uehling DT, Hopkins WJ, Beierle LM, Kryger JV, Heisey DM. Vaginal mucosal immunization for recurrent urinary tract infection: extended phase II clinical trial. J Infect Dis. 2001;183(Suppl 1):S81-3.
20. Raz R, Chazan B, Dan M. Cranberry juice and urinary tract infection. Clin Infect Dis. 2004;38:1413-9.
21. Ahuja S, Kaack B, Roberts J. Loss of fimbrial adhesion with the addition of Vaccinum macrocarpon to the growth medium of P-fimbriated Escherichia coli. J Urol. 1998;159:559-62.
22. Kontiokari T, Sundqvist K, Nuutinen M, Pokka T, Koskela M, Uhari M. Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ. 2001;322:1571.
23. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infection in women. Can J Urol. 2002;9:1558-62.
24. Avorn J, Monane M, Gurwitz JH, Glynn RJ, Choodnovskiy I, Lipsitz LA. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA. 1994;271:751-4.
25. Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections [Cochrane review]. Cochrane Database Syst Rev. 2004;(2):CD001321.
26. Beerepoot MAJ, Stobberingh EE, Geerlings SE. Onderzoek naar nietantibiotische versus antibiotische profylaxe bij vrouwen met recidiverende urineweginfecties (de NAPRUTI-studie). Ned Tijdschr Geneeskd 2006;150:574-5.